Status:
UNKNOWN
A Habit-formation and Gamification Intervention to Improve ART Adherence Among MSM HIV Patients in Mexico
Lead Sponsor:
Instituto Nacional de Salud Publica, Mexico
Collaborating Sponsors:
Hospital Civil Juan I. Menchaca
Hospital General de Occidente
Conditions:
HIV
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
In general, several studies show that adherence to antiretroviral therapy (ART) among men who have sex with men (MSM) is low. Yet, high adherence to ART is essential-not only to improve the quality of...
Detailed Description
FUERTES is an intervention with two main components: 1) the provision of a simple tool that MSM can access to learn how to develop an habit of taking their ART drugs, and 2) the support of a trained p...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- be MSM
- be 18 or more years of age
- treatment initiation between one day and one month ago, with expected continuation of treatment for the next ten months
- literate Spanish
- living in the metropolitan area of Guadalajara or Villahermosa
- willing and able to provide written informed consent and contact information ( a phone number).
- Exclusion criteria:
- cisgender or transgender woman
- transvestite, transgender or transsexual man
- living with AIDS and taking four or more medicines for opportunistic infections
- diagnosis of any neurologic, memory, sight or any other clinical illness that would prevent them answering the questionnaires
- kidney disease with creatinine clearance below 50
- presenting with acute liver failure or chronic liver failure
- negative perception towards ART (ART as pharmaceutical lie, more harmful than beneficial)
- the presence of a mental illness that requires a care assistant/guardian or treatment with psychiatric medication (e.g. schizophrenia, bipolar disorder, etc.)
- participating in another research study to improve ART adherence
- living on the street
- unwilling to provide written informed consent or contact information
- 11\) refusal to participate.
Exclusion
Key Trial Info
Start Date :
December 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT03410680
Start Date
December 5 2017
End Date
December 1 2024
Last Update
September 9 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Civil Nuevo Dr. Juan I. Menchaca
Guadalajara, Jalisco, Mexico, 44340
2
Hospital General de Occidente
Guadalajara, Jalisco, Mexico, 45170
3
CAPASITS Villahermosa
Villahermosa, Tabasco, Mexico, 86060